SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CollPlant Holdings Ltd. – ‘6-K’ for 8/6/18

On:  Monday, 8/6/18, at 6:08am ET   ·   For:  8/6/18   ·   Accession #:  1213900-18-10215   ·   File #:  1-38370

Previous ‘6-K’:  ‘6-K’ on / for 7/30/18   ·   Next:  ‘6-K’ on / for 8/8/18   ·   Latest:  ‘6-K’ on / for 4/4/24   ·   1 Reference:  By:  CollPlant Biotechnologies Ltd. – ‘424B5’ on 2/16/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/06/18  CollPlant Holdings Ltd.           6-K         8/06/18    1:16K                                    Edgar Agents LLC/FA

Current Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of Foreign Private Issuer                    HTML     10K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2018

Commission File Number 001-38370

 

CollPlant Holdings Ltd.

(Exact name of registrant as specified in its charter)

 

3 Sapir Street, Weizmann Science Park

Ness Ziona 74140, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐

 

 

 

 C: 

 

 

 

As previously disclosed, on July 26, 2018, Collplant Holdings Ltd. (the “Company”) entered into a securities purchase agreement with Ami Sagi (the “Purchase Agreement”), pursuant to which the Company agreed, upon the terms and subject to the conditions of the Purchase Agreement, to issue and sell to Ami Sagi, in a private placement, 11,125,000 ordinary shares for a purchase price of NIS 4,561,250 (approximately $1.25 million based on the exchange rate reported by the Bank of Israel on July 26, 2018).

 

On July 31, 2018, the Company completed the closing of the Purchase Agreement, which resulted in the issuance of 11,125,000 ordinary shares to Ami Sagi.

 

 C: 
  C: 1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  COLLPLANT HOLDINGS LTD.
     
Date: August 6, 2018 By:  /s/ Eran Rotem
    Name: Eran Rotem
    Title:   Deputy CEO and Chief Financial Officer

 

 

2

 


Dates Referenced Herein

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period End:8/6/18None on these Dates
7/31/18
7/26/18
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  CollPlant Biotechnologies Ltd.    424B5                  1:566K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-18-010215   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:38:38.1pm ET